DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Bellmunt J, de Wit R, Vaughn DJ. KEYNOTE-045 Investigators. et al.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
N Engl J Med 2017;
376 (Suppl. 16) 1015-1026
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.